Quick Facts
Stock Symbol:	ARQL
# of Employees:	300
Corporate HQ:	Woburn, MA
Employer Home Page:	www.arqule.com
Employer Careers Page:	www.arqule.com/wt/arc/careers

View all ArQule, Inc. jobs on BostonWorks.com

Company Description:

ArQule, Inc. is a biotechnology company engaged in research and development of next-generation small-molecule cancer therapeutics based on its innovative Activated Checkpoint TherapySM (ACT^SM) platform. ACT^SM compounds are intended to improve the way cancer patients are treated because they selectively kill cancer cells and spare normal cells by restoring and activating cellular checkpoints that are defective in cancer. The Company's lead programs are ARQ 501 for solid cancers, presently in Phase 1 clinical trials, and ARQ 101, an optimized small-molecule compound targeting p38 MAP Kinase for rheumatoid arthritis, presently in preclinical (GLP-tox) studies. In addition to advancing its own programs, ArQule continues to advance the drug discovery efforts of pharmaceutical collaborators by providing high-quality library design and compound production. For more information about ArQule, please visit the Company's new website at www.ArQule.com.